nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Respiratory failure—Vincristine—sarcoma	0.0212	0.0212	CcSEcCtD
Levobunolol—Lethargy—Dactinomycin—sarcoma	0.0173	0.0173	CcSEcCtD
Levobunolol—Cardiac failure congestive—Mitoxantrone—sarcoma	0.0162	0.0162	CcSEcCtD
Levobunolol—Cardiac arrest—Thiotepa—sarcoma	0.0162	0.0162	CcSEcCtD
Levobunolol—Ataxia—Thiotepa—sarcoma	0.016	0.016	CcSEcCtD
Levobunolol—Keratitis—Epirubicin—sarcoma	0.0146	0.0146	CcSEcCtD
Levobunolol—Cardiac arrest—Vincristine—sarcoma	0.0144	0.0144	CcSEcCtD
Levobunolol—Ataxia—Vincristine—sarcoma	0.0142	0.0142	CcSEcCtD
Levobunolol—Cardiac failure congestive—Etoposide—sarcoma	0.0135	0.0135	CcSEcCtD
Levobunolol—Keratitis—Doxorubicin—sarcoma	0.0135	0.0135	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.0129	0.0129	CcSEcCtD
Levobunolol—Conjunctivitis—Thiotepa—sarcoma	0.0128	0.0128	CcSEcCtD
Levobunolol—Erectile dysfunction—Vincristine—sarcoma	0.012	0.012	CcSEcCtD
Levobunolol—Erectile dysfunction—Mitoxantrone—sarcoma	0.0117	0.0117	CcSEcCtD
Levobunolol—Stinging—Epirubicin—sarcoma	0.0117	0.0117	CcSEcCtD
Levobunolol—Cardiac arrest—Etoposide—sarcoma	0.0116	0.0116	CcSEcCtD
Levobunolol—Depression—Vincristine—sarcoma	0.0116	0.0116	CcSEcCtD
Levobunolol—Erythema multiforme—Dactinomycin—sarcoma	0.0111	0.0111	CcSEcCtD
Levobunolol—Conjunctivitis—Mitoxantrone—sarcoma	0.011	0.011	CcSEcCtD
Levobunolol—Stinging—Doxorubicin—sarcoma	0.0108	0.0108	CcSEcCtD
Levobunolol—Arrhythmia—Thiotepa—sarcoma	0.0105	0.0105	CcSEcCtD
Levobunolol—Alopecia—Thiotepa—sarcoma	0.0104	0.0104	CcSEcCtD
Levobunolol—Bronchospasm—Etoposide—sarcoma	0.0104	0.0104	CcSEcCtD
Levobunolol—Bradycardia—Mitoxantrone—sarcoma	0.0104	0.0104	CcSEcCtD
Levobunolol—Alopecia—Dactinomycin—sarcoma	0.0103	0.0103	CcSEcCtD
Levobunolol—Atrioventricular block—Epirubicin—sarcoma	0.00975	0.00975	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00936	0.00936	CcSEcCtD
Levobunolol—Alopecia—Vincristine—sarcoma	0.00924	0.00924	CcSEcCtD
Levobunolol—Arrhythmia—Mitoxantrone—sarcoma	0.0091	0.0091	CcSEcCtD
Levobunolol—Atrioventricular block—Doxorubicin—sarcoma	0.00902	0.00902	CcSEcCtD
Levobunolol—Alopecia—Mitoxantrone—sarcoma	0.009	0.009	CcSEcCtD
Levobunolol—Confusional state—Thiotepa—sarcoma	0.00845	0.00845	CcSEcCtD
Levobunolol—Erythema multiforme—Etoposide—sarcoma	0.00801	0.00801	CcSEcCtD
Levobunolol—Diabetes mellitus—Epirubicin—sarcoma	0.00789	0.00789	CcSEcCtD
Levobunolol—Cardiac failure congestive—Epirubicin—sarcoma	0.00757	0.00757	CcSEcCtD
Levobunolol—Chest pain—Mitoxantrone—sarcoma	0.00755	0.00755	CcSEcCtD
Levobunolol—Paraesthesia—Thiotepa—sarcoma	0.00753	0.00753	CcSEcCtD
Levobunolol—Alopecia—Etoposide—sarcoma	0.00749	0.00749	CcSEcCtD
Levobunolol—Diabetes mellitus—Doxorubicin—sarcoma	0.0073	0.0073	CcSEcCtD
Levobunolol—Confusional state—Mitoxantrone—sarcoma	0.0073	0.0073	CcSEcCtD
Levobunolol—Pain—Thiotepa—sarcoma	0.00717	0.00717	CcSEcCtD
Levobunolol—Shock—Mitoxantrone—sarcoma	0.00712	0.00712	CcSEcCtD
Levobunolol—Pain—Dactinomycin—sarcoma	0.00711	0.00711	CcSEcCtD
Levobunolol—Hypoglycaemia—Epirubicin—sarcoma	0.00704	0.00704	CcSEcCtD
Levobunolol—Lethargy—Epirubicin—sarcoma	0.00701	0.00701	CcSEcCtD
Levobunolol—Cerebrovascular accident—Epirubicin—sarcoma	0.00701	0.00701	CcSEcCtD
Levobunolol—Cardiac failure congestive—Doxorubicin—sarcoma	0.00701	0.00701	CcSEcCtD
Levobunolol—Hypotension—Vincristine—sarcoma	0.00695	0.00695	CcSEcCtD
Levobunolol—Feeling abnormal—Thiotepa—sarcoma	0.00691	0.00691	CcSEcCtD
Levobunolol—Diplopia—Epirubicin—sarcoma	0.00687	0.00687	CcSEcCtD
Levobunolol—Feeling abnormal—Dactinomycin—sarcoma	0.00686	0.00686	CcSEcCtD
Levobunolol—Hypotension—Mitoxantrone—sarcoma	0.00676	0.00676	CcSEcCtD
Levobunolol—Paraesthesia—Vincristine—sarcoma	0.00667	0.00667	CcSEcCtD
Levobunolol—Urticaria—Thiotepa—sarcoma	0.00666	0.00666	CcSEcCtD
Levobunolol—Cardiac arrest—Epirubicin—sarcoma	0.00653	0.00653	CcSEcCtD
Levobunolol—Hypoglycaemia—Doxorubicin—sarcoma	0.00651	0.00651	CcSEcCtD
Levobunolol—Paraesthesia—Mitoxantrone—sarcoma	0.0065	0.0065	CcSEcCtD
Levobunolol—Loss of consciousness—Etoposide—sarcoma	0.00648	0.00648	CcSEcCtD
Levobunolol—Cerebrovascular accident—Doxorubicin—sarcoma	0.00648	0.00648	CcSEcCtD
Levobunolol—Lethargy—Doxorubicin—sarcoma	0.00648	0.00648	CcSEcCtD
Levobunolol—Ataxia—Epirubicin—sarcoma	0.00646	0.00646	CcSEcCtD
Levobunolol—Dyspnoea—Mitoxantrone—sarcoma	0.00645	0.00645	CcSEcCtD
Levobunolol—Pain—Vincristine—sarcoma	0.00636	0.00636	CcSEcCtD
Levobunolol—Diplopia—Doxorubicin—sarcoma	0.00635	0.00635	CcSEcCtD
Levobunolol—Chest pain—Etoposide—sarcoma	0.00628	0.00628	CcSEcCtD
Levobunolol—Pain—Mitoxantrone—sarcoma	0.00619	0.00619	CcSEcCtD
Levobunolol—Hypersensitivity—Thiotepa—sarcoma	0.00618	0.00618	CcSEcCtD
Levobunolol—Hypersensitivity—Dactinomycin—sarcoma	0.00613	0.00613	CcSEcCtD
Levobunolol—Confusional state—Etoposide—sarcoma	0.00607	0.00607	CcSEcCtD
Levobunolol—Cardiac arrest—Doxorubicin—sarcoma	0.00604	0.00604	CcSEcCtD
Levobunolol—Asthenia—Thiotepa—sarcoma	0.00601	0.00601	CcSEcCtD
Levobunolol—Ataxia—Doxorubicin—sarcoma	0.00597	0.00597	CcSEcCtD
Levobunolol—Asthenia—Dactinomycin—sarcoma	0.00597	0.00597	CcSEcCtD
Levobunolol—Feeling abnormal—Mitoxantrone—sarcoma	0.00596	0.00596	CcSEcCtD
Levobunolol—Pruritus—Thiotepa—sarcoma	0.00593	0.00593	CcSEcCtD
Levobunolol—Urticaria—Mitoxantrone—sarcoma	0.00575	0.00575	CcSEcCtD
Levobunolol—Diarrhoea—Thiotepa—sarcoma	0.00573	0.00573	CcSEcCtD
Levobunolol—Diarrhoea—Dactinomycin—sarcoma	0.00569	0.00569	CcSEcCtD
Levobunolol—Hypotension—Etoposide—sarcoma	0.00563	0.00563	CcSEcCtD
Levobunolol—Dizziness—Thiotepa—sarcoma	0.00554	0.00554	CcSEcCtD
Levobunolol—Hypersensitivity—Vincristine—sarcoma	0.00548	0.00548	CcSEcCtD
Levobunolol—Paraesthesia—Etoposide—sarcoma	0.00541	0.00541	CcSEcCtD
Levobunolol—Dyspnoea—Etoposide—sarcoma	0.00537	0.00537	CcSEcCtD
Levobunolol—Hypersensitivity—Mitoxantrone—sarcoma	0.00533	0.00533	CcSEcCtD
Levobunolol—Asthenia—Vincristine—sarcoma	0.00533	0.00533	CcSEcCtD
Levobunolol—Headache—Thiotepa—sarcoma	0.00525	0.00525	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00525	0.00525	CcSEcCtD
Levobunolol—Asthenia—Mitoxantrone—sarcoma	0.00519	0.00519	CcSEcCtD
Levobunolol—Pain—Etoposide—sarcoma	0.00515	0.00515	CcSEcCtD
Levobunolol—Conjunctivitis—Epirubicin—sarcoma	0.00514	0.00514	CcSEcCtD
Levobunolol—Diarrhoea—Vincristine—sarcoma	0.00509	0.00509	CcSEcCtD
Levobunolol—Nausea—Thiotepa—sarcoma	0.00498	0.00498	CcSEcCtD
Levobunolol—Feeling abnormal—Etoposide—sarcoma	0.00496	0.00496	CcSEcCtD
Levobunolol—Diarrhoea—Mitoxantrone—sarcoma	0.00495	0.00495	CcSEcCtD
Levobunolol—Nausea—Dactinomycin—sarcoma	0.00494	0.00494	CcSEcCtD
Levobunolol—Dizziness—Vincristine—sarcoma	0.00491	0.00491	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00485	0.00485	CcSEcCtD
Levobunolol—Bradycardia—Epirubicin—sarcoma	0.00484	0.00484	CcSEcCtD
Levobunolol—Urticaria—Etoposide—sarcoma	0.00478	0.00478	CcSEcCtD
Levobunolol—Conjunctivitis—Doxorubicin—sarcoma	0.00476	0.00476	CcSEcCtD
Levobunolol—Headache—Vincristine—sarcoma	0.00466	0.00466	CcSEcCtD
Levobunolol—Visual impairment—Epirubicin—sarcoma	0.00458	0.00458	CcSEcCtD
Levobunolol—Headache—Mitoxantrone—sarcoma	0.00453	0.00453	CcSEcCtD
Levobunolol—Erythema multiforme—Epirubicin—sarcoma	0.00449	0.00449	CcSEcCtD
Levobunolol—Bradycardia—Doxorubicin—sarcoma	0.00447	0.00447	CcSEcCtD
Levobunolol—Hypersensitivity—Etoposide—sarcoma	0.00444	0.00444	CcSEcCtD
Levobunolol—Nausea—Vincristine—sarcoma	0.00441	0.00441	CcSEcCtD
Levobunolol—Asthenia—Etoposide—sarcoma	0.00432	0.00432	CcSEcCtD
Levobunolol—Nausea—Mitoxantrone—sarcoma	0.0043	0.0043	CcSEcCtD
Levobunolol—Pruritus—Etoposide—sarcoma	0.00426	0.00426	CcSEcCtD
Levobunolol—Arrhythmia—Epirubicin—sarcoma	0.00424	0.00424	CcSEcCtD
Levobunolol—Visual impairment—Doxorubicin—sarcoma	0.00424	0.00424	CcSEcCtD
Levobunolol—Alopecia—Epirubicin—sarcoma	0.0042	0.0042	CcSEcCtD
Levobunolol—Erythema multiforme—Doxorubicin—sarcoma	0.00416	0.00416	CcSEcCtD
Levobunolol—Diarrhoea—Etoposide—sarcoma	0.00412	0.00412	CcSEcCtD
Levobunolol—Dizziness—Etoposide—sarcoma	0.00398	0.00398	CcSEcCtD
Levobunolol—Arrhythmia—Doxorubicin—sarcoma	0.00393	0.00393	CcSEcCtD
Levobunolol—Alopecia—Doxorubicin—sarcoma	0.00388	0.00388	CcSEcCtD
Levobunolol—Headache—Etoposide—sarcoma	0.00377	0.00377	CcSEcCtD
Levobunolol—Syncope—Epirubicin—sarcoma	0.00371	0.00371	CcSEcCtD
Levobunolol—Palpitations—Epirubicin—sarcoma	0.00365	0.00365	CcSEcCtD
Levobunolol—Loss of consciousness—Epirubicin—sarcoma	0.00363	0.00363	CcSEcCtD
Levobunolol—Nausea—Etoposide—sarcoma	0.00358	0.00358	CcSEcCtD
Levobunolol—Chest pain—Epirubicin—sarcoma	0.00352	0.00352	CcSEcCtD
Levobunolol—Syncope—Doxorubicin—sarcoma	0.00343	0.00343	CcSEcCtD
Levobunolol—Confusional state—Epirubicin—sarcoma	0.0034	0.0034	CcSEcCtD
Levobunolol—Palpitations—Doxorubicin—sarcoma	0.00338	0.00338	CcSEcCtD
Levobunolol—Loss of consciousness—Doxorubicin—sarcoma	0.00336	0.00336	CcSEcCtD
Levobunolol—Shock—Epirubicin—sarcoma	0.00332	0.00332	CcSEcCtD
Levobunolol—Chest pain—Doxorubicin—sarcoma	0.00326	0.00326	CcSEcCtD
Levobunolol—Hypotension—Epirubicin—sarcoma	0.00315	0.00315	CcSEcCtD
Levobunolol—Confusional state—Doxorubicin—sarcoma	0.00315	0.00315	CcSEcCtD
Levobunolol—Shock—Doxorubicin—sarcoma	0.00307	0.00307	CcSEcCtD
Levobunolol—Paraesthesia—Epirubicin—sarcoma	0.00303	0.00303	CcSEcCtD
Levobunolol—Dyspnoea—Epirubicin—sarcoma	0.00301	0.00301	CcSEcCtD
Levobunolol—Hypotension—Doxorubicin—sarcoma	0.00292	0.00292	CcSEcCtD
Levobunolol—Pain—Epirubicin—sarcoma	0.00289	0.00289	CcSEcCtD
Levobunolol—Paraesthesia—Doxorubicin—sarcoma	0.0028	0.0028	CcSEcCtD
Levobunolol—Dyspnoea—Doxorubicin—sarcoma	0.00278	0.00278	CcSEcCtD
Levobunolol—Feeling abnormal—Epirubicin—sarcoma	0.00278	0.00278	CcSEcCtD
Levobunolol—Urticaria—Epirubicin—sarcoma	0.00268	0.00268	CcSEcCtD
Levobunolol—Pain—Doxorubicin—sarcoma	0.00267	0.00267	CcSEcCtD
Levobunolol—Feeling abnormal—Doxorubicin—sarcoma	0.00257	0.00257	CcSEcCtD
Levobunolol—Hypersensitivity—Epirubicin—sarcoma	0.00249	0.00249	CcSEcCtD
Levobunolol—Urticaria—Doxorubicin—sarcoma	0.00248	0.00248	CcSEcCtD
Levobunolol—Asthenia—Epirubicin—sarcoma	0.00242	0.00242	CcSEcCtD
Levobunolol—Pruritus—Epirubicin—sarcoma	0.00239	0.00239	CcSEcCtD
Levobunolol—Diarrhoea—Epirubicin—sarcoma	0.00231	0.00231	CcSEcCtD
Levobunolol—Hypersensitivity—Doxorubicin—sarcoma	0.0023	0.0023	CcSEcCtD
Levobunolol—Asthenia—Doxorubicin—sarcoma	0.00224	0.00224	CcSEcCtD
Levobunolol—Dizziness—Epirubicin—sarcoma	0.00223	0.00223	CcSEcCtD
Levobunolol—Pruritus—Doxorubicin—sarcoma	0.00221	0.00221	CcSEcCtD
Levobunolol—Diarrhoea—Doxorubicin—sarcoma	0.00214	0.00214	CcSEcCtD
Levobunolol—Headache—Epirubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Levobunolol—Dizziness—Doxorubicin—sarcoma	0.00207	0.00207	CcSEcCtD
Levobunolol—Nausea—Epirubicin—sarcoma	0.002	0.002	CcSEcCtD
Levobunolol—Headache—Doxorubicin—sarcoma	0.00196	0.00196	CcSEcCtD
Levobunolol—Nausea—Doxorubicin—sarcoma	0.00185	0.00185	CcSEcCtD
